Cargando…

PReS-FINAL-2179: Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis

Detalles Bibliográficos
Autores principales: Burgos-Vargas, R, Tse, S, Horneff, G, Pangan, AL, Unnebrink, K, Anderson, JK
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044167/
http://dx.doi.org/10.1186/1546-0096-11-S2-O14
_version_ 1782319096566644736
author Burgos-Vargas, R
Tse, S
Horneff, G
Pangan, AL
Unnebrink, K
Anderson, JK
author_facet Burgos-Vargas, R
Tse, S
Horneff, G
Pangan, AL
Unnebrink, K
Anderson, JK
author_sort Burgos-Vargas, R
collection PubMed
description
format Online
Article
Text
id pubmed-4044167
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40441672014-06-17 PReS-FINAL-2179: Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis Burgos-Vargas, R Tse, S Horneff, G Pangan, AL Unnebrink, K Anderson, JK Pediatr Rheumatol Online J Oral Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4044167/ http://dx.doi.org/10.1186/1546-0096-11-S2-O14 Text en Copyright © 2013 Burgos-Vargas et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Oral Presentation
Burgos-Vargas, R
Tse, S
Horneff, G
Pangan, AL
Unnebrink, K
Anderson, JK
PReS-FINAL-2179: Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis
title PReS-FINAL-2179: Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis
title_full PReS-FINAL-2179: Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis
title_fullStr PReS-FINAL-2179: Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis
title_full_unstemmed PReS-FINAL-2179: Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis
title_short PReS-FINAL-2179: Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis
title_sort pres-final-2179: efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044167/
http://dx.doi.org/10.1186/1546-0096-11-S2-O14
work_keys_str_mv AT burgosvargasr presfinal2179efficacyandsafetyofadalimumabinpediatricpatientswithenthesitisrelatedarthritis
AT tses presfinal2179efficacyandsafetyofadalimumabinpediatricpatientswithenthesitisrelatedarthritis
AT horneffg presfinal2179efficacyandsafetyofadalimumabinpediatricpatientswithenthesitisrelatedarthritis
AT panganal presfinal2179efficacyandsafetyofadalimumabinpediatricpatientswithenthesitisrelatedarthritis
AT unnebrinkk presfinal2179efficacyandsafetyofadalimumabinpediatricpatientswithenthesitisrelatedarthritis
AT andersonjk presfinal2179efficacyandsafetyofadalimumabinpediatricpatientswithenthesitisrelatedarthritis